Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Omics Studio ApS
APS
Active
CVR 44905345
Niels Jernes Vej 10
Other software publishing · NACE 5829
Est. 2024
2 employees
https://omicsstudio.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 249K
EBITDA margin
-411.4%
Equity ratio
-79.5%
Financial strength
Net profit 2025
DKK -854K
2 employees
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2025
Key figures
Annual report 2025
Revenue
DKK 249K
—
EBITDA
DKK -1M
—
Net profit
DKK -854K
—
Total assets
DKK 772K
—
Equity
DKK -614K
—
Employees
2
—
Company information
Legal name
Omics Studio ApS
CVR number
44905345
Legal form
Anpartsselskab
NACE code
5829 · Other software publishing
Founded
18. juni 2024
Share capital
DKK 240.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning til dette.
Contact
Address
Niels Jernes Vej 10
Phone
+4571117590
Email
contact@omicsstudio.com
Website
https://omicsstudio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other software publishing
Companies in Aalborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2025
Income statement
DKK thousands
Item
2025
Revenue
249
Staff expenses
-1.272
EBITDA
-1.023
Depreciation & amort.
-29
EBIT
-1.052
Net financials
-66
Profit before tax
-1.119
Tax
-265
Net profit
-854
Balance sheet
DKK thousands
Item
2025
Total assets
772
Equity
-614
Long-term debt
1.316
Short-term debt
70
Total debt
1.386
Financial ratios
5-year trend
EBITDA margin
-411.4%
This company
15.8%
Market median
-2704% vs market
2025
2025
Equity ratio
-79.5%
This company
38.2%
Market median
-308% vs market
2025
2025
Return on equity
-85393600.0%
This company
18.4%
Market median
-464095752% vs market
2025
2025
Net profit margin
-343.3%
This company
8.1%
Market median
-4338% vs market
2025
2025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
2025
2025
Debt / equity
2.26×
This company
0.62×
Market median
-265% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-06-18 – 2025-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
PF
Patrick Frostholm Østergaard
Management
Management
2024
—
—
KK
Kenneth Kastaniegaard
Chief Executive Officer
Chief Executive Officer
2024
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
LL
Louis Loeb
Chairman
2024
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Kastaniegaard Holding ApS
Company
33.3%
33.3%
2024
L.Loeb Holding ApS
Company
33.3%
33.3%
2024
Pattrigue Holding ApS
Company
5.0%
5.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
L.Loeb Holding ApS
Omics Studio ApS
(this company)
Board network connections
Board members of Omics Studio ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Patrick Frostholm Østergaard
Management
0 companies
Kenneth Kastaniegaard
Chief Executive Officer
0 companies
Louis Loeb
Chairman
0 companies